Cosette Pharmaceuticals, Inc.

Who: Cosette Pharmaceuticals/Mayne Pharma Group Ltd. What: Cosette is acquiring struggling Mayne to strengthen its position in women’s health and dermatology in a take-private transaction. Why: C

Cosette Pharmaceuticals has named Brad Leonard as head of its generics business and Vincent Colicchio as chief of operations, as the New Jersey-based firm seeks to drive its “next phase of growth and

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sionna Gets CF Compounds AbbVie License

The US Food and Drug Administration has given the green light to Cosette Pharmaceuticals to launch the first generic version of originator AbbVie ’s Rectiv (nitroglycerin) ointment, 0.4%. The agenc